Search results for "Bran"

showing 10 items of 6477 documents

Surgical Management of Retraction Pockets: Does Mastoidectomy have a Role?

2021

Abstract Introduction Retraction pocket is a condition in which the eardrum lies deeper within the middle ear. Its management has no consensus in literature. Objective To assess the role of mastoidectomy in the management of retraction pockets added to a tympanoplasty. Methods Prospective study of patients with retraction pocket and referred to surgery. The patients were randomly assigned to two groups: one managed with tympanoplasty and mastoidectomy and the other group with tympanoplasty only. The minimum follow-up considered was 12 months. The outcomes were: integrity of eardrum, recurrence, and hearing status. Results This study included 43 patients. In 24 cases retraction occurred in t…

medicine.medical_specialtymastoidectomymedicine.medical_treatmentlcsh:MedicineMastoidectomyMastoidectomy Middle ear Ossiculoplasty Otitis media Tympanic membrane Tympanoplasty03 medical and health sciences0302 clinical medicinetympanoplastymedicineossiculoplasty030223 otorhinolaryngologyOriginal Researchtympanic membraneOssicular chainAir volumebusiness.industrylcsh:Rotitis mediaTympanoplastylcsh:Otorhinolaryngologylcsh:RF1-547Settore MED/32 - AudiologiaSurgerySettore MED/31 - Otorinolaringoiatriamedicine.anatomical_structureOtorhinolaryngologymiddle ear030220 oncology & carcinogenesisMiddle earbusinessEardrumHearing.statusRetraction pocketInternational Archives of Otorhinolaryngology
researchProduct

BENZODIAZEPINE RECEPTOR BINDING IN RAT BRAIN AND RAT SPINAL CORD MEMBRANES

1978

medicine.medical_specialtymedicine.anatomical_structureEndocrinologyMembraneChemistryInternal medicinemedicineSpinal cordRat brainBenzodiazepine receptor binding
researchProduct

MRI in the Diagnosis of Right Ventricular Dysplasia

2006

ARVD is part of the group of cardiomyopathies characterised pathologically by fibrofatty replacement of the right ventricular myocardium and clinically by right ventricular arrhythmias of the LBBB pattern. Pathogenesis, prevalence, and aetiology are yet not fully known. The diagnosis of ARVD is based on the presence of structural, histological, electrocardiographic, and genetic factors. Therapeutic options include antiarrhythmic medication, catheter ablation, implantable cardioverter defibrillation, and surgery. Angiography and echocardiography lack sensitivity and specificity in the diagnosis of ARVD. MR imaging allows a three-dimensional evaluation of especially the right ventricle, and p…

medicine.medical_specialtymedicine.diagnostic_testDefibrillationbusiness.industryLeft bundle branch blockmedicine.medical_treatmentCatheter ablationVentricular tachycardiamedicine.diseasemedicine.anatomical_structureVentricleInternal medicineAngiographymedicineCardiologyEtiologyVentricular outflow tractbusiness
researchProduct

PO-58 - Cardiovascular risk profile in survivors of adult cancer - results from the general population study.

2016

The advancements in cancer treatment and detection of early cancer have resulted in steady increase of adult cancer survivors over the years. However, due to the long term toxic effects of chemotherapy and radiotherapy, the incidence of cardiovascular diseases (CVD) is increasing in survivors. Identifying risk factors and interventions to reduce the excess burden of CVD in this vulnerable population is urgently needed.To investigate the cardiovascular risk factors (CVRFs), inflammation and coagulation profile in cancer survivors from a large population-based study.Presence of CVRFs and laboratory markers have been compared in individuals with (n=1,359) and without (n=13,626) history of canc…

medicine.medical_specialtymedicine.diagnostic_testbiologybusiness.industrymedicine.medical_treatmentIncidence (epidemiology)CancerHematologyFibrinogenmedicine.diseaseRadiation therapy03 medical and health sciences0302 clinical medicineVon Willebrand factorDiabetes mellitusInternal medicinemedicinebiology.proteinPhysical therapyPopulation study030211 gastroenterology & hepatologybusinessLipid profilemedicine.drugThrombosis research
researchProduct

CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure

2021

Abstract Background Intrarenal venous flow (IRVF) measured by Doppler ultrasound has gained interest as a potential surrogate marker of renal congestion and adverse outcomes in heart failure. In this work, we aimed to determine if antigen carbohydrate 125 (CA125) and plasma amino-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with congestive IRVF patterns (i.e., biphasic and monophasic) in acute heart failure (AHF). Methods and results We prospectively enrolled a consecutive cohort of 70 patients hospitalized for AHF. Renal Doppler ultrasound was assessed within the first 24-h of hospital admission. The mean age of the sample was 73.5 ± 12.3 years; 47.1% were female, and…

medicine.medical_specialtymedicine.drug_classCarbohydrates030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineVenous flow03 medical and health sciencesCA1250302 clinical medicineInterquartile rangeIntrarrenal Doppler ultrasoundInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumans030212 general & internal medicineHeart FailureOriginal Scientific PaperSurrogate endpointbusiness.industryCardiorenalMembrane ProteinsAcute heart failureGeneral Medicinemedicine.diseasePrognosisPeptide FragmentsROC CurveHeart failureCA-125 AntigenCohortNTproBNPCardiologyCongestionFemaleDoppler ultrasoundCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionBiomarkers
researchProduct

Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

2018

Abstract Background Prediction models for venous thromboembolism recurrence will likely be improved by adding levels of coagulation factors. Risk assessment is ideally performed during anticoagulant treatment, however, the influence of direct oral anticoagulants on coagulation factors is uncertain. Objective To assess the influence of rivaroxaban and apixaban on several coagulation factor levels. Methods In two crossover trials we assessed the influence of rivaroxaban and apixaban intake on factor (F)VIII, FXI and FXII‐activity and fibrinogen, von Willebrand factor (VWF:Ag), and d‐dimer levels. At three sessions with a washout period in between, blood was taken from 12 healthy male individu…

medicine.medical_specialtymedicine.drug_mechanism_of_actionFactor Xa Inhibitorapixabanfactor Xa inhibitors030204 cardiovascular system & hematologyTreatment resultsFibrinogenGastroenterology03 medical and health sciences0302 clinical medicineVon Willebrand factorInternal medicinecoagulantsMedicinerivaroxabanBlood coagulation testRivaroxabanbiologybusiness.industryBrief Reportblood coagulation testsrisk assessmentHematologyCoagulation030220 oncology & carcinogenesisbiology.proteinApixabanbusinessOriginal Articles: Thrombosismedicine.drug
researchProduct

Therapeutic Advances in Emergency Cardiology: Acute Pulmonary Embolism.

2019

Background Acute pulmonary embolism (PE) requires rapid diagnosis and early and appropriate treatment, often under conditions of hemodynamic instability. The therapeutic strategy should optimally integrate the therapeutic arsenal in a multidisciplinary but unitary approach. Areas of uncertainty The short list of the major uncertainties associated with acute PE should include limited general public awareness on venous thromboembolism, acute hemodynamic support not based on evidence from randomized clinical trials, with few updates lately, mainly linked to extracorporeal membrane oxygenation, thrombolytic therapy having firm indications only in high-risk PE, without clear strategies for parti…

medicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyInferior vena cavaExtracorporeallaw.invention03 medical and health sciencesTherapeutic approach0302 clinical medicineRandomized controlled triallawmedicineExtracorporeal membrane oxygenationHumansPharmacology (medical)Decompensation030212 general & internal medicineIntensive care medicineStrokePharmacologybusiness.industryGeneral Medicinemedicine.diseasePulmonary embolismPatient Care ManagementTreatment Outcomemedicine.veinbusinessPulmonary EmbolismAmerican journal of therapeutics
researchProduct

Non-responders to cardiac resynchronization therapy: Insights from multimodality imaging and electrocardiography. A brief review

2016

Background Cardiac resynchronization therapy (CRT) is a successful strategy for heart failure (HF) patients. The pre-requisite for the response is the evidence of electrical dyssynchrony on the surface electrocardiogram usually as left bundle branch block (LBBB). Non-response to CRT is a significant problem in clinical practice. Patient selection, inadequate delivery and sub-optimal left ventricle lead position may be important causes. Objectives In an effort to improve CRT response multimodality imaging (especially echocardiography, computed tomography and cardiac magnetic resonance) could play a decisive role and extensive literature has been published on the matter. However, we are so fa…

medicine.medical_specialtymedicine.medical_treatmentCardiac resynchronization therapyHeart failure030204 cardiovascular system & hematologyMultimodal ImagingMultimodality imagingMultimodalityCardiac Resynchronization TherapyElectrocardiography03 medical and health sciencesQRS complex0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineResponse rate (survey)medicine.diagnostic_testbusiness.industryLeft bundle branch blockMedicine (all)Responsemedicine.diseaseTreatment Outcomemedicine.anatomical_structureCardiac resynchonization therapyVentricleHeart failurecardiovascular systemCardiologyRadiologyCardiology and Cardiovascular MedicinebusinessElectrocardiographyInternational Journal of Cardiology
researchProduct

Clarithromycin in the Management of Chronic Rhinosinusitis: Preliminary Results of a Possible Its New Use

2018

The aim of this study is to evaluate the efficacy and safety of prolonged therapy with low-dose clarithromycin in patients with chronic rhinosinusitis with polyps (CRSwP) after endoscopic sinus surgery (ESS). A total of 10 patients with CRSwP were identified and subjected to bilateral ESS. In post-operative patients they were treated with nasal wash with saline solution and steroid sprays (beclomethasone). During follow-up, after 30–40 days after the operation (M = 35.4 SD = +4.33), patients reported a worsening of symptoms with onset of nasal obstruction; reduction/loss of smell; headache; onset of viscous secretions and therefore all patients continued therapy with saline nasal irrigation…

medicine.medical_specialtymedicine.medical_treatmentMucous membrane of noseEosinophilGastroenterology03 medical and health sciences0302 clinical medicineHyposmiaEdemaInternal medicineClarithromycinClarithromycinmedicineChronic rhinosinusitis with polyp030223 otorhinolaryngologyTopical Steroid TherapySalineNosebusiness.industryOtorhinolaryngology2734 Pathology and Forensic MedicineChronic rhinosinusitis with polypsSurgerymedicine.anatomical_structureOtorhinolaryngologyOtorhinolaryngology030220 oncology & carcinogenesisOriginal ArticleSurgeryChronic rhinosinusitis with polyps; Clarithromycin; Eosinophilmedicine.symptombusinessmedicine.drug
researchProduct

Survival with low- and high-flux dialysis

2021

The National Program of I + D + I 2008–2011 and Instituto de Salud Carlos III (ISCIII), the ISCIII Retic REDinREN (RD06/0016/1013, RD12/0021/0023 and RD16/ 0009/0017), the ISCIII (ICI14/00107, PI17/00384 and PI20/00633), Fondo Europeo de Desarrollo Regional (FEDER), Plan Estatal de I + D + I 2013–2016, Plan de Ciencia, Tecnología e Innovación 2013–2017 y 2018–2022 del Principado de Asturias (GRUPIN14-028, IDI-2018-000152) (...)

medicine.medical_specialtymedicine.medical_treatmentPopulation030232 urology & nephrology610030204 cardiovascular system & hematologyPeritoneal dialysis03 medical and health sciences0302 clinical medicineInternal medicinemedicineddc:610AcademicSubjects/MED00340educationDialysisTransplantationeducation.field_of_studychronic haemodialysisbusiness.industryMortality rateHazard ratioOriginal ArticlesmortalityNephrologyRelative riskPropensity score matchingdialysismortality riskHemodialysisbusinessdialysis membranes
researchProduct